Immunoblot analysis of tumor extracts from each group showed that TA reduced S6K1 phosphorylation on Thr389, which is required for its kinase activity (Dennis et al., 1998; McMahon et al., 2002), to a greater extent on average than the other treatments (Figure 4B). Here, RPS6KB1 is linked to neoplasm.